Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of chronic myelomonocytic leukemia. Vincristine and prednisone therapy during symptomatic phase or after transformation to acute leukemia.

× No keyword cloud information.

13 in total

Review 1. Chronic myelomonocytic leukemia in adults.

Authors: P A Miescher; J J Farguet
Journal: Semin Hematol Date: 1974-04 Impact factor: 3.851

2. Subacute myelomonocytic leukemia. Clinical, morphologic and ultrastructural studies of 10 cases.

Authors: J Sexauer; L Kass; B Schnitzer
Journal: Am J Med Date: 1974-12 Impact factor: 4.965

3. Chronic erythromonocytic leukemia.

Authors: G O Broun
Journal: Am J Med Date: 1969-11 Impact factor: 4.965

4. In vitro evidence for an unusual progenitor cell in acute monocytic leukemia.

Authors: R Taetle; L Ivor
Journal: Cancer Date: 1980-10-01 Impact factor: 6.860

5. Proposals for the classification of the myelodysplastic syndromes.

Authors: J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal: Br J Haematol Date: 1982-06 Impact factor: 6.998

6. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study.

Authors: S M Marks; D Baltimore; R McCaffrey
Journal: N Engl J Med Date: 1978-04-13 Impact factor: 91.245

7. "Pure" monocytic or histiomonocytic leukemia: a revised concept.

Authors: M T Shaw; R E Nordquist
Journal: Cancer Date: 1975-01 Impact factor: 6.860

8. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors: J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal: Br J Haematol Date: 1976-08 Impact factor: 6.998

9. Terminal deoxynucleotidyl transferase-containing cells in peripheral blood: implications for the surveillance of patients with lymphoblastic leukemia or lymphoma in remission.

Authors: T W Froehlich; G R Buchanan; J A Cornet; P A Sartain; R G Smith
Journal: Blood Date: 1981-08 Impact factor: 22.113

10. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy.

Authors: M Tanaka; T Kaneda; Y Hirota; S Yoshida; K Kitajima
Journal: Am J Hematol Date: 1980 Impact factor: 10.047

1 in total

1. Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy.

Authors: Sarah Culver; Daisuke Ito; Luke Borst; Jerold S Bell; Jaime F Modiano; Matthew Breen
Journal: Vet Clin Pathol Date: 2013-06-25 Impact factor: 1.180

1 in total